Jane Street’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Jane Street’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-81,900	Closed	-$3.08M	–	10864
2021 Q1	$3.08M	Buy	81,900 +59,200	+261%	+$1.48M	﹤0.01%	3189
2020 Q4	$386K	Buy	+22,700	New	+$284K	﹤0.01%	6089

Jane Street's FPRX Position: Q2 2021 in Review

Jane Street sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 35,842 shares — an estimated $1.35M sold.

Jane Street first reported a position in FPRX in Q2 2015 and held it in 9 quarters. The position peaked at $1.35M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Jane Street reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Jane Street sold 35,842 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $1.35M.
Jane Street first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 9 quarters.
Jane Street's Five Prime Therapeutics, Inc. position peaked at $1.35M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.